IE
RCUS icon

Israel Englander’s Arcus Biosciences RCUS Stock Holding History

Israel Englander’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,400
Closed -$768K – 6406
2024
Q2 		$768K Buy
50,400
+400
+0.8% +$6.46K ﹤0.01% 4297
2024
Q1 		$944K Buy
+50,000
New +$865K ﹤0.01% 4340
2023
Q4 		– Sell
-231,300
Closed -$4.15M – 6456
2023
Q3 		$4.15M Buy
231,300
+26,000
+13% +$522K ﹤0.01% 2870
2023
Q2 		$4.17M Buy
205,300
+95,300
+87% +$1.81M ﹤0.01% 2828
2023
Q1 		$2.01M Hold
110,000
– – ﹤0.01% 3441
2022
Q4 		$2.27M Buy
110,000
+59,000
+116% +$1.62M ﹤0.01% 3464
2022
Q3 		$1.33M Sell
51,000
-64,300
-56% -$1.7M ﹤0.01% 4098
2022
Q2 		$2.92M Sell
115,300
-133,700
-54% -$3.27M ﹤0.01% 3334
2022
Q1 		$7.86M Buy
249,000
+154,000
+162% +$5.16M ﹤0.01% 2427
2021
Q4 		$3.85M Buy
95,000
+65,000
+217% +$2.52M ﹤0.01% 3158
2021
Q3 		$1.05M Buy
30,000
+15,000
+100% +$467K ﹤0.01% 4628
2021
Q2 		$412K Buy
15,000
+5,000
+50% +$143K ﹤0.01% 5465
2021
Q1 		$281K Hold
10,000
– – ﹤0.01% 5258
2020
Q4 		$260K Buy
+10,000
New +$242K ﹤0.01% 4648

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Israel Englander's RCUS Position: Q2 2026 in Review

Israel Englander opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 133,110 shares worth $4.1M. The stake represents ﹤0.01% of the portfolio and ranks #3179 among its holdings. This is a return to the name: Israel Englander previously reported a position in RCUS as recently as Q4 2025.

Israel Englander first reported a position in RCUS in Q1 2018 and has held it in 29 quarters since. The position peaked at $13.8M in Q4 2024. 228 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Israel Englander held 133,110 shares of Arcus Biosciences worth $4.1M as of Q2 2026.
  • Arcus Biosciences was a new Israel Englander position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3179 holding.
  • Israel Englander first reported a position in Arcus Biosciences in Q1 2018 and has held it in 29 quarters since.
  • Israel Englander's Arcus Biosciences position peaked at $13.8M in Q4 2024.
  • 228 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.